methyl N-benzylalanine ester hydrochloride | 16975-44-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl N-benzylalanine ester hydrochloride
• 英文别名: N-benzylalanine methyl ester hydrochloride；N-Benzyl-alanin-methylester; Hydrochlorid；Methyl 2-(benzylamino)propanoate hydrochloride；methyl 2-(benzylamino)propanoate;hydrochloride
• CAS: 16975-44-3
• 化学式: C₁₁H₁₅NO₂*ClH
• mdl: MFCD28383848
• 分子量: 229.707
• InChiKey: FJUWPAKLUHULRE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.72
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Boc-beta-丙氨酸 、 methyl N-benzylalanine ester hydrochloride 在 1-羟基苯并三唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 methyl N-tert-butoxycarbony-β-alanyl-N-benzyl-alaninate
  参考文献：
  名称：

  WO2008/8518

  摘要：

  公开号：

文献信息

• [EN] BICYCLIC HETEROCYCLES AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS<br/>[FR] HÉTÉROCYCLES BICYCLIQUES ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RÉCEPTEUR CCR2
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011042399A1

  公开（公告）日：2011-04-14

  The invention is concerned with novel bicyclic compounds of formula (I), wherein A, L, E, F, G, R1, R2, R3, R4, R5, R6, R7, V, W and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.

  这项发明涉及具有以下结构式（I）的新颖双环化合物，其中A、L、E、F、G、R1、R2、R3、R4、R5、R6、R7、V、W和n如描述和权利要求中所定义，并且其生理上可接受的盐。这些化合物是CCR2受体、CCR5受体和/或CCR3受体的拮抗剂，可用作药物。
• NOVEL BICYCLIC COMPOUNDS
  申请人：Aebi Johannes

  公开号：US20110082294A1

  公开（公告）日：2011-04-07

  The invention is concerned with novel bicyclic compounds of formula (I), wherein A, L, E, F, G, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , V, W and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.

  该发明涉及具有以下结构的新型双环化合物（I），其中A、L、E、F、G、R1、R2、R3、R4、R5、R6、R7、V、W和n的定义如描述和索赔中所定义，并且其生理上可接受的盐。这些化合物是CCR2受体、CCR5受体和/或CCR3受体的拮抗剂，可用作药物。
• A simple and general synthesis of 4-oxo-4,5,6,7-tetrahydroindoles via a novel intramolecular 1,3-dipolar cycloaddition approach
  作者：Darrell R. Hutchison、Naresh K. Nayyar、Michael J. Martinelli

  DOI：10.1016/0040-4039(96)00426-1

  日期：1996.4

  A general synthesis of 4-keto-4,5,6,7-tetrahydroindoles 6–12 has been achieved in two steps using a new intramolecular 1,3-dipolar cycloaddition approach in moderate yields (45–60%). The potential of this methodology is demonstrated by the synthesis of a mitomycin skeleton (15) and a topoisomerase-1 inhibitor skeleton (17).

  使用新的分子内1,3-偶极环加成方法可分两步实现4-酮-4,5,6,7-四氢吲哚6-12的一般合成，产率中等（45-60％）。这种方法的潜力通过丝裂霉素骨架（15）和拓扑异构酶-1抑制剂骨架（17）的合成得到证明。
• New Approach for the General Synthesis of Oxotetrahydroindoles via Intramolecular Cycloadditions of Azomethine Ylides with Tethered Alkynes
  作者：Naresh K. Nayyar、Darrell R. Hutchison、Michael J. Martinelli

  DOI：10.1021/jo9614598

  日期：1997.2.1

  A new method for the synthesis of oxotetrahydroindoles has been achieved employing an intramolecular dipolar cycloaddition approach involving mesoionic species (munchnones) with electron-deficient alkynes. The methodology is quite general and convergent as shown by the synthesis of a variety of tri- and tetrasubstituted oxotetrahydroindoles 18, 21, 24, 27, 30, and 34. LiI-based ester cleavage in the presence of an electrophilic acetylenic ketone was critical for formation of the requisite cycloaddition substrates. The cycloaddition is virtually unaffected by the presence of gem-dimethyl groups in the side chain (cf. 38). The presence of a substituted benzyl or a phenethyl moiety on nitrogen, a polarized acetylene, and an appropriate tether between dipole and dipolarophile are essential for obtaining optimal efficiency.
• BICYCLIC HETEROCYCLES AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS
  申请人：F.Hoffmann-La Roche AG

  公开号：EP2486042A1

  公开（公告）日：2012-08-15